Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Measured vs Queen RX

Measured
Graded #58

Higher grade

vs+9.099999999999994
Queen RX
Graded #214

Lower grade

The verdict

Measured takes it — 75.1/100 to 66/100.

Measured grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMeasured +10
86
76
Dose & formulationMeasured +20
77
57
Clinical oversightMeasured +18
87
69
Labs & monitoringMeasured +10
63
53
FulfillmentQueen RX +8
67
75
Contract termsQueen RX +20
41
61
Measured · left barQueen RX · right bar

The numbers

MetricMeasuredQueen RX
WeighScore75.1/10066/100
GradeCC
Scorecard rank#58#214
Semaglutide$119/mo (compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$229/mo (compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Measured

Graded #58 · C

Strengths

  • Membership includes 1:1 nutrition support and board-certified provider care
  • Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
  • Insurance or cash-pay options for brand-name medications
  • Oral option available (Wegovy pill); cancel-anytime membership

Where it loses points

  • Membership ($49/mo) is billed separately on top of medication cost
  • Compounded medications are not FDA-approved
  • Compounding/dispensing pharmacies not individually named
  • State availability not published
Queen RX

Graded #214 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard